N-(4-(N-(5-Methylisoxazol-3-yl)sulfamoyl)phenyl)acetamide, 95.0%, 100mg

Propanamide, N-(6-chloro-3-pyridazinyl)-2,2-dimethyl-, 95%, 100g

2-{[(4-tert-butylphenyl)sulfonyl]amino}propanoic acid, 95.0%, 500mg

Ethyl 5-ethyl-1H-pyrrole-2-carboxylate, 98%, 100mg

Methyl 4-fluoro-2-methoxybenzoate, 95.0%, 5g

2-Bromo-3-methylpyridine 1-oxide, 95.0%, 250mg

4-(2-Bromo-phenyl)-3-chlorosulfonyl-5-trifluoromethyl-thiophene-2-carboxylic acid methyl ester, 95.0%, 1g

tert-Butyl 4-(piperidine-4-carbonyl)piperazine-1-carboxylate, 97%, 5g

Ethyl 2-oxocyclohexanecarboxylate, 95.0%, 500g

NAD, min. 95%, for biochemistry, 5 g, glass packaging

5-Bromo-4-(trifluoromethyl)pyrimidin-2(1H)-one, 95.0%, 10g

HPLC column NUCLEODUR® NH2 5 µm, 250 mm, 4.6 mm, 1 Piece(s)

2,7-Dibromo-2',3',5',6'-tetrahydrospiro[fluorene-9,4'-pyran], 95.0%, 100mg